Theragen Etex Co.Ltd (066700) — Capital Reinvestment Ratio

Latest as of March 2026: 0.29x

Theragen Etex Co.Ltd (066700) has a Capital Reinvestment Ratio of 0.29x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩3.08 Billion) in capital expenditures (₩897.88 Million). Check tangible equity quality of Theragen Etex Co.Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.29x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.08 Billion
KRW

Capital Expenditures

₩897.88 Million
KRW

Data as of

Mar 2026
Most recent filing

Theragen Etex Co.Ltd Capital Reinvestment Ratio (2008–2025)

This chart tracks Theragen Etex Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Theragen Etex Co.Ltd cash conversion from operations.

Annual Capital Reinvestment Ratio for Theragen Etex Co.Ltd (2008–2025)

Year-by-year Capital Reinvestment Ratio for Theragen Etex Co.Ltd from 2008 to 2025. See free cash flow generation of Theragen Etex Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.47x ₩10.97 Billion ₩5.20 Billion ▼ -92.6%
2024 6.37x ₩1.79 Billion ₩11.39 Billion ▲ +1510.4%
2023 0.40x ₩12.12 Billion ₩4.80 Billion ▼ -9.5%
2022 0.44x ₩9.59 Billion ₩4.19 Billion ▼ -36.3%
2021 0.69x ₩4.01 Billion ₩2.75 Billion ▲ +201.3%
2020 0.23x ₩13.23 Billion ₩3.01 Billion ▼ -99.8%
2019 123.01x ₩37.69 Million ₩4.64 Billion ▲ +7384.3%
2017 1.64x ₩1.78 Billion ₩2.92 Billion ▼ -96.4%
2014 45.34x ₩39.95 Million ₩1.81 Billion ▲ +37789.2%
2008 0.12x ₩3.14 Billion ₩376.03 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow